AI Article Synopsis
- A case study describes the occurrence of a full thickness macular hole in a 65-year-old man after receiving brolucizumab injections for neovascular age-related macular degeneration, a complication not previously reported.
- The patient had a history of multiple anti-VEGF injections and developed the macular hole following his treatment.
- Surgical intervention through pars plana vitrectomy successfully repaired the macular hole, highlighting the need for vigilance regarding rare complications after brolucizumab injections.
Article Abstract
Purpose: To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date.
Case Description: A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole.
Outcome: Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated.
Conclusion: Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/11206721241286708 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!